Lausanne, 1 December 2009 – The FEI has announced today (1 December) that the FEI Bureau has passed a Resolution delaying implementation of the new Equine Prohibited Substances List and the accompanying Equine Anti-Doping and Controlled Medication Regulations until 5 April 2010. This Resolution has been passed in order to allow for broader debate and consultation on the policy change approved at the recent FEI General Assembly regarding the restricted use of a small number of non-steroidal anti-inflammatory drugs (NSAIDs).
The FEI recognizes that a number of issues arise as a result of this policy change, which was voted in by a majority of 53-48 at the meeting in Copenhagen on 19 November. The change in policy will affect National Federations and organizers who must comply with state laws as well as international competition rules. It has implications for the breeding industry and the selection of horses and may impact on all those concerned with animal welfare. It also affects the laboratories involved in the testing procedures. The decision, which reversed the 1993 ban on phenylbutazone, has provoked considerable debate among FEI stakeholders.
The FEI acknowledges that these concerns are all legitimate and feels that there is clearly a need for further debate on the issue. The delayed implementation of the new Equine Prohibited Substances List will also allow for supplementary research to be carried out on the use of NSAIDs in the competition horse. Read more> http://www.horsesinthesouth.com/article/article_detail.aspx?id=9052
Tags: Equine Protection, FEI, Horse Care, NSAIDs, Prohibited Substances
December 1, 2009